TY - JOUR
T1 - The Impact of MRI Features and Observer Confidence on the Treatment Decision-Making for Patients with Untreated Glioma
AU - Due-Tønnessen, Paulina
AU - Pinho, Marco C.
AU - Emblem, Kyrre E.
AU - Hald, John K.
AU - Kanoto, Masafumi
AU - Abildgaard, Andreas
AU - Sederevicius, Donatas
AU - Groote, Inge R.
AU - Rapalino, Otto
AU - Bjørnerud, Atle
N1 - Funding Information:
We thank the patients and their relatives for involvement in the study. This work received funding from the Research Council of Norway grant 191088/F20 (AB) and FRIPRO grant 261984 (KEE), the SouthEastern Norway Regional Health Authority grants 2017073 (KEE) and 2013069 (KEE), and the European Research Council (ERC) under the European Union’s Horizon 2020 Programme (ERC Grant Agreement No. 758657-ImPRESS) (KEE).
Publisher Copyright:
© 2019, The Author(s).
PY - 2019/12/1
Y1 - 2019/12/1
N2 - In a blind, dual-center, multi-observer setting, we here identify the pre-treatment radiologic features by Magnetic Resonance Imaging (MRI) associated with subsequent treatment options in patients with glioma. Study included 220 previously untreated adult patients from two institutions (94 + 126 patients) with a histopathologically confirmed diagnosis of glioma after surgery. Using a blind, cross-institutional and randomized setup, four expert neuroradiologists recorded radiologic features, suggested glioma grade and corresponding confidence. The radiologic features were scored using the Visually AcceSAble Rembrandt Images (VASARI) standard. Results were retrospectively compared to patient treatment outcomes. Our findings show that patients receiving a biopsy or a subtotal resection were more likely to have a tumor with pathological MRI-signal (by T2-weighted Fluid-Attenuated Inversion Recovery) crossing the midline (Hazard Ratio; HR = 1.30 [1.21–1.87], P < 0.001), and those receiving a biopsy sampling more often had multifocal lesions (HR = 1.30 [1.16–1.64], P < 0.001). For low-grade gliomas (N = 50), low observer confidence in the radiographic readings was associated with less chance of a total resection (P = 0.002) and correlated with the use of a more comprehensive adjuvant treatment protocol (Spearman = 0.48, P < 0.001). This study may serve as a guide to the treating physician by identifying the key radiologic determinants most likely to influence the treatment decision-making process.
AB - In a blind, dual-center, multi-observer setting, we here identify the pre-treatment radiologic features by Magnetic Resonance Imaging (MRI) associated with subsequent treatment options in patients with glioma. Study included 220 previously untreated adult patients from two institutions (94 + 126 patients) with a histopathologically confirmed diagnosis of glioma after surgery. Using a blind, cross-institutional and randomized setup, four expert neuroradiologists recorded radiologic features, suggested glioma grade and corresponding confidence. The radiologic features were scored using the Visually AcceSAble Rembrandt Images (VASARI) standard. Results were retrospectively compared to patient treatment outcomes. Our findings show that patients receiving a biopsy or a subtotal resection were more likely to have a tumor with pathological MRI-signal (by T2-weighted Fluid-Attenuated Inversion Recovery) crossing the midline (Hazard Ratio; HR = 1.30 [1.21–1.87], P < 0.001), and those receiving a biopsy sampling more often had multifocal lesions (HR = 1.30 [1.16–1.64], P < 0.001). For low-grade gliomas (N = 50), low observer confidence in the radiographic readings was associated with less chance of a total resection (P = 0.002) and correlated with the use of a more comprehensive adjuvant treatment protocol (Spearman = 0.48, P < 0.001). This study may serve as a guide to the treating physician by identifying the key radiologic determinants most likely to influence the treatment decision-making process.
UR - http://www.scopus.com/inward/record.url?scp=85077303777&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077303777&partnerID=8YFLogxK
U2 - 10.1038/s41598-019-56333-x
DO - 10.1038/s41598-019-56333-x
M3 - Article
C2 - 31882644
AN - SCOPUS:85077303777
SN - 2045-2322
VL - 9
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 19898
ER -